Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0058
-0.0001 (-1.69%)
At close: Jul 7, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $242.7 thousand as of July 9, 2026. Its market cap has decreased by -98.68% in one year.
Market Cap
242.70K
Enterprise Value
-1.77M
Revenue
52.63M
Ranking
n/a
PE Ratio
0.03
Stock Price
$0.01
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 242.70K, a decrease of -99.84%. That is a compound annual growth rate of -85.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 242.70K | -86.51% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioMedix | 402.23K |
| Actavia Life Sciences | 385.91K |
| IO Biotech | 366.94K |
| Altamira Therapeutics | 365.79K |
| Sorrento Therapeutics | 299.04K |
| Regenerative Medical Technology Group | 289.06K |
| CNBX Pharmaceuticals | 232.84K |
| Ampio Pharmaceuticals | 207.88K |